|
IL181886D0
|
|
Loxapine analogs and pharmaceutical compositions containing the same
|
|
WO2007092334A1
|
|
Method of treating sleep disorders
|
|
WO2007092333A1
|
|
Use of olopatadine for treating sleep disorders
|
|
US2007043021A1
|
|
Olanzapine analogs and methods of use thereof
|
|
WO2006116615A1
|
|
Benzisoxazole piperazine compounds and methods of use thereof
|
|
CN101208314A
|
|
Benzisoxazole piperazine compounds and methods of use thereof
|
|
BRPI0515518A
|
|
loxapine analogues and methods of their use
|
|
US2006094705A1
|
|
Quetiapine analogs and methods of use thereof
|
|
CN101060847A
|
|
Loxapine analogs and methods of use thereof
|
|
US2005256165A1
|
|
Doxepin analogs and methods of use thereof
|
|
US2005239838A1
|
|
Methods of treating sleep disorders
|
|
US7326721B2
|
|
Doxepin analogs and methods of use thereof
|
|
WO2004112705A2
|
|
Methods for treating sleep disorders
|
|
US7355042B2
|
|
Treatment of CNS disorders using CNS target modulators
|
|
US7411069B2
|
|
Doxepin analogs and methods of use thereof
|
|
AU2003210598A1
|
|
Treatment of sleep disorders using sleep target modulators
|
|
US2003187021A1
|
|
Treatment of sleep disorders using CNS target modulators
|
|
CA2463579A1
|
|
Treatment of cns disorders using cns target modulators
|
